Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Chromatography Products Catalog

January 14, 2008 10:00 am | Product Releases | Comments

Grace Davison Discovery Sciences was formed through the acquisitions of Alltech, Davisil, Flexit, Grom, Jones Chromatography, MODcol, and Vydac.

TOPICS:

Qualification Tool

January 14, 2008 9:52 am | Product Releases | Comments

Waters introduced the SystemsQT qualification tool for Waters HPLC and Waters ACQUITY UltraPerformance LC (UPLC) systems in an Empower software environment.

TOPICS:

Liquid Handler

January 14, 2008 9:46 am | Product Releases | Comments

Labcyte introduces the Echo 520 liquid handler, which was developed for the medium-throughput laboratory.

TOPICS:
Advertisement

High-Capacity Electrochemical HPLC

January 14, 2008 9:37 am | Product Releases | Comments

ESA Biosciences has launched new HPLC systems designed to help expedite drug-metabolism studies and support medicinal chemistry efforts by electrochemically synthesizing significant quantities of difficult-to-obtain metabolites.

TOPICS:

Sample Prep Devices for UHPLC

January 14, 2008 9:34 am | Product Releases | Comments

Millipore provides syringe filters, membranes, and holders in many configurations that are designed and manufactured to maximize ultra-high pressure liquid chromatography (UHPLC) system performance.

TOPICS:

Sample Volume Transfection

January 14, 2008 9:26 am | Product Releases | Comments

BTX has introduced a new MicroPoration technology for transfection of 10µl to 100µl sample volumes.

TOPICS:

Interface Software

January 14, 2008 9:18 am | Product Releases | Comments

Shimadzu has released the interface software to Waters Empower Chromatography data processing software for controlling Shimadzu’s Prominence HPLC series.

TOPICS:

Contract Development Solutions

January 14, 2008 9:17 am | Product Releases | Comments

Invetech will showcase its integrated contract development and manufacturing services at LabAutomation2008.

TOPICS:
Advertisement

FAIMS-based LC/MS

January 14, 2008 9:11 am | Product Releases | Comments

Researchers in Germany’s A&M Labs have validated a method that uses Thermo Scientific high-Field Asymmetric waveform Ion Mobility Spectrometry (FAIMS) technology to remove interferences from a drug analysis.

TOPICS:

MALDI Spotting

January 14, 2008 8:54 am | Product Releases | Comments

Eksigent announces the addition of a NanoLC MALDI Spotting System to its nanoflow chromatography product line.

TOPICS:

Late Night With LRIG at LabAutomation2008

January 14, 2008 8:38 am | News | Comments

The Association for Laboratory Automation (ALA) and the Laboratory Robotics Interest Group (LRIG),  announced that 15 companies were selected for Late Night with LRIG – A Rapid Fire Innovation Session.

TOPICS:

ALA Names Innovation Award Finalists

January 14, 2008 7:41 am | News | Comments

The Association for Laboratory Automation (ALA) announced the finalists for its $10,000 Innovation Award, which recognizes outstanding innovation and contributions to automation technologies in the laboratory.

TOPICS:

Menveo Shown to Provide Immunogenicity

January 14, 2008 7:08 am | News | Comments

Menveo, a vaccine in development by Novartis, may protect infants using a schedule beginning at two months of age against four of the most common causes of meningococcal disease.

TOPICS:

Takeda Submits New Drug Application for Alogliptin

January 14, 2008 6:58 am | News | Comments

Takeda Global Research & Development Center submitted a New Drug Application to the FDA for alogliptin, a highly selective dipeptidyl peptidase-4 inhibitor under investigation for the treatment of type 2 diabetes.

TOPICS:

Oncolytics Biotech Files Phase 1/2 Clinical Trial

January 14, 2008 6:50 am | News | Comments

The U.S. National Cancer Institute has filed a protocol for a Phase 1/2 clinical trial for patients with metastatic ovarian, peritoneal, or fallopian tube cancers using concurrent systemic and intraperitoneal administration of Reolysin, Oncolytics Biotech's’ formulation of the human reovirus.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading